financetom
Market
financetom
/
Market
/
Kotak Equities prefers Bajaj Finserv; recommends “reduce” on Bajaj Finance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kotak Equities prefers Bajaj Finserv; recommends “reduce” on Bajaj Finance
Jul 16, 2020 7:09 AM

Domestic brokerage Kotak Institutional Equities seems divided over Bajaj Finance and Bajaj Finserve given the changes and challenging circumstances faced by these Bajaj Group companies post COVID-19 pandemic. The brokerage has downgraded Bajaj Finance to Reduce from Buy but raised the fair value of the stock to Rs 2,800 from Rs 2,700 per share earlier. It, however, recommends buying Bajaj Finserv for a target of Rs 7,150 post-roll-over to June 2020.

Share Market Live

NSE

The brokerage believes near-term risks to asset quality and growth persist for Bajaj Finance, while it does not find the risk-reward equilibrium in favor anymore post the sharp rally in stock price recently.

Bajaj Finance stock has risen over 78 percent since its 52-week low of Rs 1,783.10 hit on May 27, 2020. The rally was fuelled by optimism over strong business fundamentals amid the ongoing COVID-19 led disruptions.

However, Kotak Institutional Equities believes that the stock trades at rich valuation of 4.4X book FY2022E. “Even as long-term potential remains strong, current valuations are completely ignoring near-term risks to the business from higher-than-expected credit costs following the moratorium and sluggish business momentum due to the lockdown leading to pressure on growth and subsequently PPOP,” the brokerage said in a note.

Sales finance AUM are expected to decline sharply at 30 percent YoY in FY2021 due to weak disbursements in 1H and shorter tenure of the product. Additionally, the company will likely tighten credit underwriting norms in this business posy the pandemic due to high credit losses in case of default, the brokerage feels.

The brokerage suggests to book profits and play through Bajaj Finserv. It expects a more gradual improvement from here while the lockdown in select parts of the country affecting recoveries and disbursements is not ruled out either.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Feb 26, 2025
08:47 AM EST, 02/26/2025 (MT Newswires) -- Technology stocks rose pre-bell Wednesday as the Technology Select Sector SPDR Fund (XLK) advanced by 1.1% and the SPDR S&P Semiconductor ETF (XSD) was up 2.4% recently. Super Micro Computer ( SMCI ) shares were over 19% higher after the company said it regained compliance with the Nasdaq's filing requirements. ...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Spurred by Potential Tax-Cuts, Nvidia Earnings Momentum
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Spurred by Potential Tax-Cuts, Nvidia Earnings Momentum
Feb 26, 2025
08:18 AM EST, 02/26/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.7% in Wednesday's premarket activity amid renewed optimism over President Trump's tax-cut agenda and the upcoming Nvidia earnings report. US stock futures were also higher, with S&P 500...
Quantum Biopharma up in U.S. Pre-market, Says Phase 1 Lucid-MS Trial Completed With no Safety Concerns
Quantum Biopharma up in U.S. Pre-market, Says Phase 1 Lucid-MS Trial Completed With no Safety Concerns
Feb 26, 2025
08:53 AM EST, 02/26/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) rose 6.6% in U.S. pre-market trading on Wednesday after saying its Phase 1 trial investigating the safety and pharmacokinetics of its lead candidate Lucid-MS has been completed with no serious adverse events being reported. According to a statement, a final safety review committee meeting concluded that Lucid-MS was...
US Equity Futures Rise Pre-Bell as Traders Await Nvidia Earnings
US Equity Futures Rise Pre-Bell as Traders Await Nvidia Earnings
Feb 26, 2025
08:18 AM EST, 02/26/2025 (MT Newswires) -- US equity futures were higher pre-bell Wednesday as traders awaited earnings results from artificial intelligence chip market bellweather Nvidia ( NVDA ) . The Dow Jones Industrial Average futures gained 0.2%, S&P 500 futures increased 0.4%, and Nasdaq futures were up 0.6%. Nvidia ( NVDA ) is scheduled to release its quarterly earnings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved